A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Clinical trial NCT01260194 · TERMINATED
Trial details
- NCT number
- NCT01260194
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-01-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.